Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions

Brain Pathology

Volumn 23, Issue 1, 2013, Pages 2-12

  Schirmer, Lucas ^a,b   Merkler, Doron ^a,c   König, Fatima B ^a   Brück, Wolfgang ^a   Stadelmann, Christine ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

axonal regeneration; GAP43; multiple sclerosis (MS); neuronal plasticity; traumatic brain injury (TBI)

Indexed keywords

AMYLOID PRECURSOR PROTEIN; NEUROMODULIN; SYNAPTOPHYSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL SWELLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVE REGENERATION; PHAGOCYTE; PROTEIN EXPRESSION; SPHEROID CELL; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN PRECURSOR; AXONS; BIOPSY; BRAIN INJURIES; CEREBRAL CORTEX; FEMALE; GAP-43 PROTEIN; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEURONS; REGENERATION; SYNAPTOPHYSIN; YOUNG ADULT;

EID: 84870902956     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00608.x     Document Type: Article

References (48)

1. Bar-Or A, Rieckmann P, Traboulsee A, Yong VW, (2011) Targeting progressive neuroaxonal injury: lessons from multiple sclerosis. CNS Drugs 25: 783-799.
2. Blaylock RL, Maroon J, (2011) Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis. Surg Neurol Int 2: 107.
3. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ, (1994) Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344: 1055-1056. (Pubitemid 24310039)
4. Buki A, Povlishock JT, (2006) All roads lead to disconnection?-Traumatic axonal injury revisited. Acta Neurochir (Wien) 148: 181-193. (Pubitemid 43139150)
5. Charcot JM, (1868) Histologie de la sclérose en plaque. Gaz Hop Civils Militaires 41: 554-555, 557-558, 566.
6. Cragg BG, (1970) What is the signal for chromatolysis? Brain Res 23: 1-21.
7. Dahl D, Perides G, Bignami A, (1989) Axonal regeneration in old multiple sclerosis plaques. Immunohistochemical study with monoclonal antibodies to phosphorylated and non-phosphorylated neurofilament proteins. Acta Neuropathol 79: 154-159. (Pubitemid 19286141)
8. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, et al, (1998) Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121: 1469-1477. (Pubitemid 28349900)
9. Doinikow B, (1915) Über De-Regenerationserscheinungen an Achsenzylindern bei der multiplen Sklerose. Z Ges Neurol Psychiat 27: 151-178.
10. Farkas O, Povlishock JT, (2007) Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res 161: 43-59. (Pubitemid 47018312)
11. Ferguson B, Matyszak MK, Esiri MM, Perry VH, (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120: 393-399. (Pubitemid 27153632)
12. Frey D, Laux T, Xu L, Schneider C, Caroni P, (2000) Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol 149: 1443-1454.
13. Greer JE, McGinn MJ, Povlishock JT, (2011) Diffuse traumatic axonal injury in the mouse induces atrophy, c-Jun activation, and axonal outgrowth in the axotomized neuronal population. J Neurosci 31: 5089-5105.
14. Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, et al, (2011) Oxidative damage in multiple sclerosis lesions. Brain 134: 1914-1924.
15. Herdegen T, Skene P, Bahr M, (1997) The c-Jun transcription factor-bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci 20: 227-231. (Pubitemid 27158053)
16. Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R, (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53: 292-304. (Pubitemid 36258633)
17. Kerschensteiner M, Bareyre FM, Buddeberg BS, Merkler D, Stadelmann C, Bruck W, et al, (2004) Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med 200: 1027-1038. (Pubitemid 39431127)
18. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, et al, (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 87: 1561-1565.
19. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W, (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125: 2202-2212.
20. Li Y, Jiang N, Powers C, Chopp M, (1998) Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 29: 1972-1980. (Pubitemid 28400003)
21. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H, (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717. (Pubitemid 30390191)
22. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al, (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365: 2188-2197.
23. Mahad D, Ziabreva I, Lassmann H, Turnbull D, (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131: 1722-1735. (Pubitemid 351957459)
24. Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, et al, (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132: 1161-1174.
25. Medana IM, Esiri MM, (2003) Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126: 515-530. (Pubitemid 36240854)
26. Meeuwsen S, Persoon-Deen C, Bsibsi M, Ravid R, van Noort JM, (2003) Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43: 243-253. (Pubitemid 37047680)
27. Merkler D, Metz GA, Raineteau O, Dietz V, Schwab ME, Fouad K, (2001) Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 21: 3665-3673. (Pubitemid 32422831)
28. Nikić I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, et al, (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17: 495-499.
29. Okada Y, Yamazaki H, Sekine-Aizawa Y, Hirokawa N, (1995) The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell 81: 769-780.
30. Oppenheimer DR, (1968) Microscopic lesions in the brain following head injury. J Neurol Neurosurg Psychiatry 31: 299-306.
31. Peterson JW, Bo L, Mork S, Chang A, Trapp BD, (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50: 389-400. (Pubitemid 32848742)
32. Radzun HJ, Hansmann ML, Heidebrecht HJ, Bodewadt-Radzun S, Wacker HH, Kreipe H, et al, (1991) Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Invest 65: 306-315.
33. Raineteau O, Schwab ME, (2001) Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2: 263-273. (Pubitemid 33673067)
34. Rocca MA, Ceccarelli A, Rodegher M, Misci P, Riccitelli G, Falini A, et al, (2010) Preserved brain adaptive properties in patients with benign multiple sclerosis. Neurology 74: 142-149.
35. Schirmer L, Albert M, Buss A, Schulz-Schaeffer WJ, Antel JP, Bruck W, Stadelmann C, (2009) Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord. Ann Neurol 66: 698-704.
36. Schirmer L, Antel JP, Bruck W, Stadelmann C, (2011) Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol 21: 428-440.
37. Sharp DJ, Beckmann CF, Greenwood R, Kinnunen KM, Bonnelle V, De BX, et al, (2011) Default mode network functional and structural connectivity after traumatic brain injury. Brain 134: 2233-2247.
38. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S, (1994) Markers of axonal injury in post mortem human brain. Acta Neuropathol 88: 433-439. (Pubitemid 24331029)
39. Singleton RH, Povlishock JT, (2004) Identification and characterization of heterogeneous neuronal injury and death in regions of diffuse brain injury: evidence for multiple independent injury phenotypes. J Neurosci 24: 3543-3553. (Pubitemid 38481111)
40. Stadelmann C, (2011) Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol 24: 224-229.
41. Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H, (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125: 75-85. (Pubitemid 34084038)
42. Stagi M, Dittrich PS, Frank N, Iliev AI, Schwille P, Neumann H, (2005) Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J Neurosci 25: 352-362. (Pubitemid 40105605)
43. Sternberger LA, Sternberger NH, (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 80: 6126-6130. (Pubitemid 14228257)
44. Tetzlaff W, Zwiers H, Lederis K, Cassar L, Bisby MA, (1989) Axonal transport and localization of B-50/GAP-43-like immunoreactivity in regenerating sciatic and facial nerves of the rat. J Neurosci 9: 1303-1313. (Pubitemid 19116750)
45. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L, (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285. (Pubitemid 28065253)
46. Vogt J, Paul F, Aktas O, Muller-Wielsch K, Dorr J, Dorr S, et al, (2009) Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol 66: 310-322.
47. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM, (2006) Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67: 960-967. (Pubitemid 44454585)
48. Wilkinson AE, Bridges LR, Sivaloganathan S, (1999) Correlation of survival time with size of axonal swellings in diffuse axonal injury. Acta Neuropathol 98: 197-202. (Pubitemid 29355553)